Clinical Features of COVID-19-Related Liver Functional Abnormality
- PMID: 32283325
- PMCID: PMC7194865
- DOI: 10.1016/j.cgh.2020.04.002
Clinical Features of COVID-19-Related Liver Functional Abnormality
Abstract
Background & aims: Some patients with SARS-CoV-2 infection have abnormal liver function. We aimed to clarify the features of COVID-19-related liver damage to provide references for clinical treatment.
Methods: We performed a retrospective, single-center study of 148 consecutive patients with confirmed COVID-19 (73 female, 75 male; mean age, 50 years) at the Shanghai Public Health Clinical Center from January 20 through January 31, 2020. Patient outcomes were followed until February 19, 2020. Patients were analyzed for clinical features, laboratory parameters (including liver function tests), medications, and length of hospital stay. Abnormal liver function was defined as increased levels of alanine and aspartate aminotransferase, gamma glutamyltransferase, alkaline phosphatase, and total bilirubin.
Results: Fifty-five patients (37.2%) had abnormal liver function at hospital admission; 14.5% of these patients had high fever (14.5%), compared with 4.3% of patients with normal liver function (P = .027). Patients with abnormal liver function were more likely to be male, and had higher levels of procalcitonin and C-reactive protein. There was no statistical difference between groups in medications taken before hospitalization; a significantly higher proportion of patients with abnormal liver function (57.8%) had received lopinavir/ritonavir after admission compared to patients with normal liver function (31.3%). Patients with abnormal liver function had longer mean hospital stays (15.09 ± 4.79 days) than patients with normal liver function (12.76 ± 4.14 days) (P = .021).
Conclusions: More than one third of patients admitted to the hospital with SARS-CoV-2 infection have abnormal liver function, and this is associated with longer hospital stay. A significantly higher proportion of patients with abnormal liver function had received lopinavir/ritonavir after admission; these drugs should be given with caution.
Keywords: ALP; Antiviral Drug; Liver Injury; Prognosis.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Comment in
-
The Topic of COVID-19-Related Liver Injury Needs More Rigorous Research.Clin Gastroenterol Hepatol. 2020 Nov;18(12):2848. doi: 10.1016/j.cgh.2020.04.073. Epub 2020 May 1. Clin Gastroenterol Hepatol. 2020. PMID: 32371168 Free PMC article. No abstract available.
-
Clinical Characteristics of COVID-19 in Patients With Liver Injury.Clin Gastroenterol Hepatol. 2020 Nov;18(12):2846-2847. doi: 10.1016/j.cgh.2020.04.043. Epub 2020 May 11. Clin Gastroenterol Hepatol. 2020. PMID: 32407783 Free PMC article. No abstract available.
-
We Know Liver Biochemistries Are Elevated in COVID-19, But Should We Be Concerned?Clin Gastroenterol Hepatol. 2020 Sep;18(10):2384-2385. doi: 10.1016/j.cgh.2020.05.018. Epub 2020 May 16. Clin Gastroenterol Hepatol. 2020. PMID: 32425706 Free PMC article. No abstract available.
-
COVID-19 Related Liver Injury: Call for International Consensus.Clin Gastroenterol Hepatol. 2020 Nov;18(12):2848-2851. doi: 10.1016/j.cgh.2020.05.013. Epub 2020 May 17. Clin Gastroenterol Hepatol. 2020. PMID: 32425707 Free PMC article. No abstract available.
-
Clinical Features and Outcomes of Coronavirus Disease 2019 (COVID-19) Patients With Chronic Hepatitis B Virus Infection.Clin Gastroenterol Hepatol. 2020 Oct;18(11):2633-2637. doi: 10.1016/j.cgh.2020.06.011. Epub 2020 Jun 15. Clin Gastroenterol Hepatol. 2020. PMID: 32553905 Free PMC article. No abstract available.
-
Reply.Clin Gastroenterol Hepatol. 2020 Nov;18(12):2851-2852. doi: 10.1016/j.cgh.2020.07.005. Epub 2020 Jul 10. Clin Gastroenterol Hepatol. 2020. PMID: 32755553 Free PMC article. No abstract available.
-
COVID-19 Morbidity and Severity in Patients With Nonalcoholic Fatty Liver Disease in South Korea: A Nationwide Cohort Study.Clin Gastroenterol Hepatol. 2022 May;20(5):e1217-e1218. doi: 10.1016/j.cgh.2021.07.031. Epub 2021 Jul 24. Clin Gastroenterol Hepatol. 2022. PMID: 34311112 Free PMC article. No abstract available.
Similar articles
-
COVID-19: Abnormal liver function tests.J Hepatol. 2020 Sep;73(3):566-574. doi: 10.1016/j.jhep.2020.04.006. Epub 2020 Apr 13. J Hepatol. 2020. PMID: 32298767 Free PMC article.
-
[Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Aug;32(8):928-932. doi: 10.3760/cma.j.cn121430-20200513-00656. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32912404 Chinese.
-
Clinical characteristics of non-ICU hospitalized patients with coronavirus disease 2019 and liver injury: A retrospective study.Liver Int. 2020 Jun;40(6):1321-1326. doi: 10.1111/liv.14449. Epub 2020 Apr 12. Liver Int. 2020. PMID: 32239591 Free PMC article.
-
Lopinavir/ritonavir for the treatment of SARS, MERS and COVID-19: a systematic review.Eur Rev Med Pharmacol Sci. 2020 Aug;24(16):8592-8605. doi: 10.26355/eurrev_202008_22659. Eur Rev Med Pharmacol Sci. 2020. PMID: 32894567
-
AGA Institute Rapid Review of the Gastrointestinal and Liver Manifestations of COVID-19, Meta-Analysis of International Data, and Recommendations for the Consultative Management of Patients with COVID-19.Gastroenterology. 2020 Jul;159(1):320-334.e27. doi: 10.1053/j.gastro.2020.05.001. Epub 2020 May 11. Gastroenterology. 2020. PMID: 32407808 Free PMC article.
Cited by
-
COVID-19 and the liver: overview.Eur J Gastroenterol Hepatol. 2021 Mar 1;33(3):309-311. doi: 10.1097/MEG.0000000000001808. Eur J Gastroenterol Hepatol. 2021. PMID: 32558697 Free PMC article. Review.
-
Characteristics of pregnant patients with COVID-19 and liver injury.J Hepatol. 2020 Oct;73(4):989-991. doi: 10.1016/j.jhep.2020.06.022. Epub 2020 Jun 20. J Hepatol. 2020. PMID: 32569609 Free PMC article. No abstract available.
-
Recent advances in COVID-19-induced liver injury: causes, diagnosis, and management.Inflammopharmacology. 2024 Oct;32(5):2649-2680. doi: 10.1007/s10787-024-01535-7. Epub 2024 Aug 10. Inflammopharmacology. 2024. PMID: 39126569 Review.
-
Fighting the War Against COVID-19 via Cell-Based Regenerative Medicine: Lessons Learned from 1918 Spanish Flu and Other Previous Pandemics.Stem Cell Rev Rep. 2021 Feb;17(1):9-32. doi: 10.1007/s12015-020-10026-5. Stem Cell Rev Rep. 2021. PMID: 32789802 Free PMC article. Review.
-
Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis.Ann Hepatol. 2021 Mar-Apr;21:100273. doi: 10.1016/j.aohep.2020.10.001. Epub 2020 Oct 16. Ann Hepatol. 2021. PMID: 33075578 Free PMC article.
References
-
- World Health Organization WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at... Available at: Accessed February 20, 2020.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous